![]() |
市場調查報告書
商品編碼
1304504
全球短鏈果寡糖(scFOS)市場 - 2023-2030年Global Short-chain Fructooligosaccharides (scFOS) Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球短鏈果寡糖(scFOS)市場規模在2022年達到5.705億美元,預計到2030年將達到12.318億美元。在2023-2030年的預測期內,該市場的年複合成長率為10.1%。
隨著人們越來越認知到腸道微生物群在整體健康中的作用,消化健康已成為消費者關注的重點領域。 ScFOS作為益生元,可滋養和促進腸道有益菌的生長,支持健康的腸道微生物群組成。 ScFOS可作為益生菌(促進腸道健康的有益菌)的營養來源。
在產品中將ScFOS與益生菌結合使用,可透過支持益生菌菌株的存活和生長而提供協同效益。 ScFOS可作為功能性配料應用於各種食品和飲料產品中。 ScFOS可被添加到各種配方中,包括乳製品、烘焙食品、穀物、飲料和營養補充劑,以增強其營養成分並提供額外的健康益處。
科學研究揭示了腸道微生物群在維持消化系統健康和整體健康中的關鍵作用。腸道細菌的組成和多樣性影響人體健康的各個方面,包括消化、免疫功能和心理健康。作為一種益生元成分,scFOS可選擇性地促進腸道有益菌的生長,以對腸道微生物群的組成產生積極影響,並有助於消化系統的健康。根據美國國家醫學圖書館(National Library of Medicine)的研究,在攝入2.5和5克/天劑量的scFOS時,腹脹會明顯加劇,但在攝入7.5和10克/天劑量時,腹脹不會加劇。
大腸急躁症(IBS)和炎症性腸病(IBD)等消化系統疾病在全球越來越普遍。因此,人們對有助於控制這些疾病和促進消化系統健康的食品和飲料產品的需求日益成長。具有益生元特性的ScFOS提供了一種天然的解決方案,有可能緩解症狀並改善腸道功能。近年來,腸道健康在整體健康中的重要性得到了廣泛關注。消費者越來越意識到健康的腸道微生物群與各方面健康之間的聯繫,包括消化、免疫功能甚至心理健康。
COVID-19分析包括COVID前情景、COVID情景和COVID後情景,以及價格動態(包括大流行期間和大流行後的價格變化,並與COVID前情景進行比較)、供需關係(由於貿易限制、封鎖和後續問題而導致的供需變化)、政府計劃(政府機構為振興市場、部門或行業而採取的計劃)和製造商戰略計劃(製造商為緩解COVID問題而採取的措施)。
The Global Short-Chain Fructooligosaccharides (scFOS) market reached US$ 570.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,231.8 million by 2030. The market is growing at a CAGR of 10.1% during the forecast period 2023-2030.
Digestive health has become a key area of focus for consumers, with increasing recognition of the role of gut microbiota in overall wellness. ScFOS, as prebiotics, nourish and promote the growth of beneficial gut bacteria, supporting a healthy gut microbiota composition. ScFOS can act as a source of nutrients for probiotics, the beneficial bacteria that promote gut health.
Combining scFOS with probiotics in products can provide synergistic benefits by supporting the survival and growth of probiotic strains. ScFOS find applications as functional ingredients in various food and beverage products. They can be incorporated into a wide range of formulations, including dairy products, baked goods, cereals, beverages, and nutritional supplements, to enhance their nutritional profile and provide additional health benefits.
Scientific research has uncovered the critical role of gut microbiota in maintaining digestive health and overall well-being. The composition and diversity of gut bacteria influence various aspects of human health, including digestion, immune function, and mental health. As a prebiotic ingredient, scFOS selectively promotes the growth of beneficial gut bacteria, which can positively impact the gut microbiota composition and contribute to digestive health. According to the National Library of Medicine, Bloating was significantly more intense during scFOS ingestion at doses of 2.5 and 5 g/d, but not at doses of 7.5 and 10 g/d.
Digestive disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are becoming more prevalent globally. As a result, there is a growing demand for food and beverage products that can help manage these conditions and promote digestive wellness. ScFOS, with its prebiotic properties, offers a natural solution that can potentially alleviate symptoms and improve gut function. The importance of gut health in overall wellness has gained significant attention in recent years. Consumers are becoming more aware of the link between a healthy gut microbiome and various aspects of health, including digestion, immune function, and even mental well-being.
The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
The global short-chain fructooligosaccharides market is segmented based on source, form, application, and region.
Short-chain fructooligosaccharides (scFOS) find extensive applications in the food and beverages industry. They are used as functional ingredients in various products, including dairy products, baked goods, cereals, beverages, and nutritional supplements. The versatility of scFOS and their compatibility with different food matrices make them popular among food and beverage manufacturers.
There is a growing consumer demand for functional foods and beverages that offer additional health benefits beyond basic nutrition. Functional ingredients like scFOS, known for their prebiotic properties and potential health benefits, are highly sought after by health-conscious consumers. The food and beverages segment responds to this demand by incorporating scFOS into its product formulations.
North America has experienced a growing demand for functional ingredients in the food and beverage industry. Consumers are increasingly seeking products that offer additional health benefits beyond basic nutrition. This demand has driven the incorporation of functional ingredients like scFOS into a wide range of food and beverage products. The North American population has shown an increased focus on health and wellness.
Consumers are becoming more aware of the importance of maintaining a healthy diet and lifestyle. As a result, there is a growing interest in products that support digestive health, weight management, and overall well-being. ScFOS, known for its prebiotic properties and potential health benefits, align with this health-conscious trend.
The major global players include: the Short-chain Fructooligosaccharides (scFOS) market are Beneo-Orafti, Jarrow Formulas Inc., Sensus B.V., Tata Sons Private Limited, Galam, Cosucra Groupe Warcoing SA, Tereos, CJ Cheiljedang Corp., Ingredion, and Meiji Food Materia Co., Ltd.
The global short-chain fructooligosaccharides market report would provide approximately 61 tables, 57 figures, and 200 pages.
LIST NOT EXHAUSTIVE